Effect of Fezolinetant on Improvement in the Anxiety/Depression Domain of the EuroQOL-5D-5L PRO: SKYLIGHT 1 and 2
Claudio N. Soares, et al.
Preliminary Analysis of Real-World Effects of Fezolinetant on Menopause-Specific Quality-of-Life Vasomotor Symptoms (MENQOL VMS) Overall and by Subgroups of Interest: Phase IV OPTION‑VMS Study
Genevieve Neal-Perry, et al.
A Claims Database Assessment of Clinical Characteristics and Treatment Patterns in Individuals Who Received Treatment for Vasomotor Symptoms Due to Menopause: A Final Analysis
Barbara DePree, et al.
